Project Grant K99NS149164
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Leland Stanford Junior University a Project Grant of $423,500 on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This two-year award, with completion scheduled for July 31, 2027, funds research investigating the mechanisms underlying cognitive dysfunction in neuromyelitis optica (NMO), a central nervous...
- Federal Project Grant Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $3.11 million Project Grant to the University of California, Los Angeles (UCLA) Office of Research Administration, effective August 1, 2025 through July 31, 2029, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This grant supports the development and validation of human induced pluripotent stem cell (iPSC)-derived hippocampal...
- Federal Project Grant Award Summary Award Details: The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant of $122,850 to the J. David Gladstone Institutes (San Francisco, CA) for the period February 15, 2026 through January 31, 2028, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). Research Products and Services: The grant funds research investigating the role of microglial dysfunction in...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Leland Stanford Junior University a Project Grant totaling $125,685 on August 9, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports research and development of a bioactive material intervention to address post-stroke dementia, a significant complication affecting approximately 7 million stroke...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded J. David Gladstone Institutes a Project Grant of $1,459,072 on August 1, 2025, under the Aging Research program (CFDA 93.866) to conduct research on Alzheimer's Disease (AD)-related neurological dysfunction. The research will deliver scientific knowledge and methodological innovations focused on understanding how inhibitory interneurons—specifically parvalbumin (PVALB) and somatostatin (SST) cell types—contribute...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Leland Stanford Junior University a Project Grant totaling $122,526.00 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on August 7, 2025. This two-year award, with a completion date of July 31, 2027, funds fundamental neuroscience research investigating the phase separation of neuronal pentraxins and their role in synapse...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded The Leland Stanford Junior University a Project Grant of $331,776.00, effective August 15, 2025, through May 31, 2030, under the Aging Research program (CFDA 93.866). This award funds research investigating the neuroimaging and genetics of the glymphatic system in Alzheimer's disease. The research will develop and validate novel, non-invasive biomarkers for characterizing the brain's waste clearance system through...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a Project Grant of $423,500 to The Leland Stanford Junior University for research activities spanning April 1, 2026, through March 31, 2028, under the Aging Research program (CFDA 93.866). The research project, titled "Uncovering Dynamic Brain Circuit Mechanisms Associated with Apathy and Disinhibition in Alzheimer's Dementia," will generate scientific knowledge and deliver research findings examining how...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded J. David Gladstone Institutes a Project Grant of $1,375,478 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025, through August 31, 2033. This eight-year award supports multidisciplinary research investigating neurovascular dysfunction and its role in neurodegeneration, central nervous system (CNS)...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant of $250,401 to The Regents of the University of Colorado (University of Colorado-Denver) on July 23, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research investigating the mechanisms by which amyloid-beta (Aβ) disrupts synaptic nanoarchitecture in Alzheimer's disease. The...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant totaling $122,526 to The Leland Stanford Junior University on May 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This research initiative, scheduled for completion by April 30, 2028, focuses on delineating Alzheimer's Disease (AD) initiation and propagation mechanisms using novel adult human brain organoids. The project deliverables include comprehensive investigations into the roles of tau tangles and amyloid-beta plaques in AD development, with particular emphasis on non-neuronal cell types including microglia and vascular cells that contribute to disease progression. The research outputs will be generated through three primary aims: identifying cell types responsible for tau and amyloid-beta seeding and spread (Aim 1); determining the role of microglia in amyloid-beta and tau deposition and propagation (Aim 2); and characterizing the role of the vasculature in AD spread while identifying early disease biomarkers (Aim 3). By utilizing an air-liquid interface adult human brain organoid culture system that preserves diverse neural cell types, the research will provide critical insights into the neurovascular microenvironment's contribution to AD initiation and progression, with potential implications for identifying novel therapeutic intervention strategies.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $122.5k | 5/14/26 |